AdvaMedDx today announced that Hologic Chief Operating Officer Eric Compton has been named chairman of the AdvaMedDx Board of Directors for a two-year term. Read more.
AdvaMedDx recently announced a global stakeholder initiative to optimize the use of diagnostic tests in the fight against antimicrobial resistance (AMR). Read more.
April 13, 2017 - 12:02pm
April 11, 2017 - 2:50pm
April 6, 2017 - 2:06pm
Hologic COO Eric Compton Named Chair of AdvaMedDx https://t.co/ruxUNbiWoa